Abernathy v. BlueCross BlueShield of Tennessee, Inc.

CourtDistrict Court, E.D. Tennessee
DecidedJuly 11, 2025
Docket3:23-cv-00322
StatusUnknown

This text of Abernathy v. BlueCross BlueShield of Tennessee, Inc. (Abernathy v. BlueCross BlueShield of Tennessee, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Abernathy v. BlueCross BlueShield of Tennessee, Inc., (E.D. Tenn. 2025).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF TENNESSEE AT KNOXVILLE

JAMES M. ABERNATHY, on his own ) behalf and on behalf of others similarly ) situated, et. al., ) Case No: 3:23-cv-322 ) Plaintiffs, ) Judge Curtis L. Collier v. ) ) Magistrate Judge Jill E. McCook BLUECROSS BLUESHIELD OF ) TENNESSEE, INC., ) ) Defendant. )

M E M O R A N D U M Before the Court is a motion by Plaintiffs Heather Hutton, Kerrie Ingle, and Courtney Conaway for an order preliminarily approving the Rule 23 settlement agreement in this action. (Doc. 36.) Plaintiffs also request that the Court approve the class-action settlement notice and conditionally appoint interim class counsel and class representatives. (Id. at 1.) Lastly, Plaintiffs request the Court to set a final approval and fairness hearing. (Id.) Defendant, BlueCross BlueShield of Tennessee, Inc., does not oppose the motion. (See id.) I. BACKGROUND On August 11, 2021, Defendant announced it would require its employees to be vaccinated against COVID-19 within six weeks. (Doc. 27 ¶ 16.) Employees could request an exemption for medical or religious reasons, and Defendant would consider the requests at its discretion on a case- by-case basis. (Id. ¶ 16–17.) Any employee who failed to vaccinate and did not receive an exemption would be terminated. (Id. ¶ 16.) Defendant offered employees a thirty-day extension period beyond the October 4, 2021 date as an opportunity for them “to pursue other positions within the company that were not subject to [Defendant’s] vaccine policy.” (Doc. 37 at 4.) Plaintiffs Heather Hutton, Kerrie Ingle, and Courtney Conaway were employees of Defendant at the time the company’s vaccine mandate was enacted. Plaintiffs each “submitted a request for a religious or medical accommodation through Defendant’s designated COVID-19 vaccination exemption process.” (Doc. 27 ¶ 18.) Plaintiffs requested an accommodation to include remote work, or alternatively, heightened safety protocols like mask wearing, social distancing, and frequent COVID-19 testing. (Id. ¶ 21.) Plaintiff Conaway submitted a medical accommodation and provided Defendant with “all requested medical information indicating the nature of her [Americans with Disabilities Act

“ADA”] qualifying disability and the associated contraindications to the COVID-19 vaccine.” (Id. ¶ 20.) Plaintiffs Hutton and Ingle submitted a religious exemption. In each of their respective accommodation requests, Plaintiffs . . . explained their belief that the COVID-19 vaccines—as well as other vaccines—were developed (either directly or through testing) using fetal cell lines derived from aborted fetal tissue and that it would be sinful to interject such products into their bodies. They believe a Christian’s body being surrendered to God is a form of spiritual worship. (See, e.g., Romans 12:1). Plaintiff [Hutton] additionally believes that the vaccine causes the body to create proteins God did not intend the body to create, which is in itself a form of disobedience to God.

(Id. ¶ 19.) After review, Defendant denied the requests. (Id. ¶ 24.) Defendant asserts, “Plaintiffs worked directly with Defendant’s members, providers, group-plan administrators, and/or customers, including those whom were immunocompromised and/or had other significant health conditions, and, without being vaccinated, they could not perform their job duties without putting themselves or others in danger upon in-person services resuming as the pandemic subsided.” (Doc. 30 ¶ 44.) Defendant determined that the proposed accommodations for public-facing employees, such as indefinite remote work, would cause Defendant’s operations and business undue hardship. (Id. at 1.) When Plaintiffs refused to get the vaccine, Defendant fired them and their similarly situated coworkers. (Doc. 27 ¶ 28.) On September 7, 2023, Plaintiffs James M. Abernathy, Heather Hutton, and Kerry Ingle filed a putative class-action complaint, alleging that Defendant discriminated against them based on their religion under Title VII, 42 U.S.C. § 2000(e) et seq.1 (Doc. 1.) On December 16, 2024, Plaintiffs amended the class-action complaint, adding Plaintiff Courtney Conaway and a claim against Defendant pursuant to the Americans with Disabilities Act (“ADA”), 42 U.S.C. § 12102 et seq. (Doc. 27 ¶ 10.) Plaintiffs allege Defendant “issu[ed] a uniform denial of all accommodation

requests.” (Id. ¶ 34.) According to Plaintiffs, “Defendant’s discriminatory actions left Plaintiffs and those similarly situated with the formidable task of choosing between their faith or health, and their jobs.” (Id. ¶ 3.) Although the parties dispute Defendant’s liability, the parties participated in an in-person mediation on November 19, 2024, with the assistance of an experienced mediator. (Doc. 37 at 5.) “The negotiations included the exchange of informal discovery regarding the size and scope of the Settlement Class and certain facts related to the strength of the claims of Plaintiffs and those similarly situated, and defenses available to [Defendant].” (Id. (citing Doc. 36-3 ¶ 18–19).) The mediation was successful and produced a settlement agreement in principle. (Id.) Plaintiffs now

move the Court for an order preliminarily approving the settlement agreement. (Doc. 36.) Defendant does not oppose the motion. (See id.)

1 On April 22, 2025, the parties stipulated to the dismissal of Plaintiff James M. Abernathy. (Doc. 35.) II. DISCUSSION The parties seek preliminary approval of the settlement agreement under Rule 23 of the Federal Rules of Civil Procedure. Approval of a Rule 23 class action settlement occurs in three steps: “(1) the court must preliminarily approve the settlement; (2) the class members must be given notice of the proposed settlement; and (3) the court must hold a hearing to determine whether the proposed settlement is fair, reasonable and adequate.” Thacker v. Chesapeake Appalachia, L.L.C., 259 F.R.D. 262, 270 (E.D. Ky. 2009) (citing Tenn. Ass’n of Health Maint. Orgs., Inc. v. Grier, 262 F.3d 559, 565–66 (6th Cir. 2001)).

The Court will first address whether the settlement agreement should be preliminarily approved. The Court will then address the proposed class notice, as well as the proposed class appointments. A. Rule 23 Preliminary Approval of Settlement At the preliminary approval stage, the Court must determine whether it “will likely be able to: (i) approve the proposal under Rule 23(e)(2); and (ii) certify the class the purposes of judgment on the proposal.” Fed. R. Civ. P. 23(e)(1)(B). The Court will address the requirements in turn. 1. Likelihood of Approval Under Rule 23(e)(2) To preliminarily approve the settlement agreement under Rule 23(e)(2), the proposed

settlement must be fair, reasonable, and adequate. To determine this, the Court considers whether: (A) the class representatives and class counsel have adequately represented the class;

(B) the proposal was negotiated at arm’s length;

(C) the relief provided for the class is adequate, taking into account:

(i) the costs, risks, and delay of trial and appeal. (ii) the effectiveness of any proposed method of distributing relief to the class, including the method of processing class-member claims;

(iii) the terms of any proposed award of attorney’s fees, including timing of payment; and

(iv) any agreement required to be identified under Rule 23(e)(3); and

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Amchem Products, Inc. v. Windsor
521 U.S. 591 (Supreme Court, 1997)
Randleman v. Fidelity National Title Insurance
646 F.3d 347 (Sixth Circuit, 2011)
Wal-Mart Stores, Inc. v. Dukes
131 S. Ct. 2541 (Supreme Court, 2011)
Gina Glazer v. Whirlpool Corporation
722 F.3d 838 (Sixth Circuit, 2013)
Cynthia Turnage v. Norfolk Southern Corporation
307 F. App'x 918 (Sixth Circuit, 2009)
William Whitlock v. FSL Management
843 F.3d 1084 (Sixth Circuit, 2016)
Joseph Terre, Jr. v. Dorsey Hopson, II
708 F. App'x 221 (Sixth Circuit, 2017)
Jane Doe v. Deja Vu Consulting, Inc.
925 F.3d 886 (Sixth Circuit, 2019)
Young v. Nationwide Mutual Insurance
693 F.3d 532 (Sixth Circuit, 2012)
Thacker v. Chesapeake Appalachia, L.L.C.
259 F.R.D. 262 (E.D. Kentucky, 2009)
Calloway v. Caraco Pharmaceutical Laboratories, Ltd.
287 F.R.D. 402 (E.D. Michigan, 2012)
Swigart v. Fifth Third Bank
288 F.R.D. 177 (S.D. Ohio, 2012)
In re Skelaxin (metaxalone) Antitrust Litigation
299 F.R.D. 555 (E.D. Tennessee, 2014)
Davidson v. Henkel Corp.
302 F.R.D. 427 (E.D. Michigan, 2014)
Granada Investments, Inc. v. DWG Corp.
962 F.2d 1203 (Sixth Circuit, 1992)
Day v. NLO, Inc.
144 F.R.D. 330 (S.D. Ohio, 1992)

Cite This Page — Counsel Stack

Bluebook (online)
Abernathy v. BlueCross BlueShield of Tennessee, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/abernathy-v-bluecross-blueshield-of-tennessee-inc-tned-2025.